Kang Min-Cheol, Kang Nalae, Ko Seok-Chun, Kim Young-Bum, Jeon You-Jin
Department of Marine Life Sciences, Jeju National University, Jeju, 690-756, Republic of Korea; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Department of Marine Life Sciences, Jeju National University, Jeju, 690-756, Republic of Korea.
Food Chem Toxicol. 2016 Apr;90:36-44. doi: 10.1016/j.fct.2016.01.023. Epub 2016 Feb 1.
The seaweeds were collected from the coast of Jeju Island, South Korea. We investigated ethanol extracts from seaweed as potential antiobesity agents by testing their effect on adipogenic differentiation in 3T3-L1 cells. Among the red algae extracts tested, the Plocamium telfairiae extract (PTE) showed the highest inhibitory effect on lipogenesis in adipocytes and, thus, was selected as a potential antiobesity agent. PTE treatment significantly decreased the expression of the adipogenic-specific proteins peroxisome proliferator-activated receptor-γ, CCAAT/enhancer-binding protein-α, sterol regulatory element-binding protein 1, and fatty acid-binding protein 4 compared with that in the untreated 3T3-L1 cells. PTE also inhibited high-fat diet (HFD)-induced obesity in male C57BL/6 mice. Oral administration of PTE significantly reduced the body weight, fatty liver, amount of white adipose tissue, and levels of triglyceride and glucose in the tested animals. Taken together, these data demonstrate that PTE can be developed as a therapeutic agent for obesity.
这些海藻采集自韩国济州岛海岸。我们通过测试海藻乙醇提取物对3T3-L1细胞脂肪生成分化的影响,来研究其作为潜在抗肥胖剂的可能性。在所测试的红藻提取物中,泰氏蜈蚣藻提取物(PTE)对脂肪细胞的脂肪生成显示出最高的抑制作用,因此被选为潜在的抗肥胖剂。与未处理的3T3-L1细胞相比,PTE处理显著降低了脂肪生成特异性蛋白过氧化物酶体增殖物激活受体γ、CCAAT/增强子结合蛋白α、固醇调节元件结合蛋白1和脂肪酸结合蛋白4的表达。PTE还抑制了雄性C57BL/6小鼠的高脂饮食(HFD)诱导的肥胖。口服PTE显著降低了受试动物的体重、脂肪肝、白色脂肪组织量以及甘油三酯和葡萄糖水平。综上所述,这些数据表明PTE可被开发为一种治疗肥胖的药物。